GLG News by Psychiatrists (EU)

This article has made a good predictive analysis of the economic climate for the medical equipments, especially amidst recent global economic recession. While the financial downfall for  medical devices in general is already showing a gloomy picture, yet the economic landslides for sales of...

This brief news is warning againts any procedural delay to market prices of generic versions of brand-name drugs. The eventual outcome is unexpected overpayment for generic brand. Is this a problem arising from computer pricing or a stratetgic decision making issue on how to label generic drugs...

The article is indicating ethical measures from the FDA relating to the risk of developing cardiovascular disease from using type 2 diabetes drug. An interesting idea for medical intervention in which decision making is underway to assess the efficacy of clinical trials...

This news has limited implications for drug development due to the mystery surrounding the causes of Alzheimer's disease. The research reported in this news article is mainly examining the potential primary role of beta-amyloid plaque to cause the onset of Alzheimer's disease. The research is useful...

The news reported in this article is no doubt showing an excellent progress made in diagnostic technique for various major illnesses, for which brain scanner is used. PET has been used to detect neurological disorder for a long time, and an additional development can ensure the successful application...

A valuable piece of information indicating an achievement to regulate and control severity of type 2 Diabetes. The article reports the findings of a clinical trial in details, the interesting outcome of weight loss in addition to blood sugar reduction may serve as indicators of possible success for...

This article is providing an excellent summary of risk factors associated with oral HRT intake. It is unsual to highlight the health cost relating to a medical therapy when treatment for post-menopausal problems is not extensive. This type of information based on research findings can no doubt benefit...

With the acceptance of SEROQUEL® (quetiapine fumarate) by the FDA to treat Bipolar disorder, medical research can yet again rely on extensive clinical trials to get confirmation of drug treatments for major psychiatric illnesses in conjunction with psychological interventions, thereby increasing...

The article presents a very important piece of information regarding the efficacy of the anti-inflammatory drugs, Naproxen and Celecoxib to treat cognitive decline of patients with neurodegenrative disorders. It presents the results of a large scale clinical trial carried out by ADAPT ((Alzheimer’s...

This is an interesting development for treating psychotic depression, particularly, for dealing with the serious side of this illness, which is causing premature death and more illnesses associated with it. The information indicates that FDA is looking forward to make a quick approval due to the urgency...